Table 2.
Top 10 cancers in Taiwan by sex between 1988 and 2016.
| Sex | Rank | 1988–1992 | 1993–1997 | 1998–2002 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cancer (ICD-O) | ASRw∗ | %∗ | Years∗ | Cancer (ICD-O) | ASRw∗ | %∗ | Years∗ | Cancer (ICD-O) | ASRw∗ | %∗ | Years∗ | ||
| Male | 1 | Liver (155) | 30.52 | 10.11 | 56.83 | Liver (155) | 38.73 | 17.56 | 58.48 | Liver (155) | 55.16 | 18.98 | 59.70 |
| 2 | Lung (162) | 26.30 | 8.55 | 64.51 | Lung (162) | 32.10 | 14.68 | 66.40 | Lung (162) | 39.97 | 14.06 | 68.13 | |
| 3 | Colorectum (153–154) | 19.83 | 6.44 | 61.35 | Colorectum (153–154) | 26.92 | 12.30 | 63.28 | Colorectum (153–154) | 36.66 | 12.76 | 64.95 | |
| 4 | Stomach (151) | 19.50 | 6.22 | 63.91 | Stomach (151) | 18.95 | 8.59 | 65.75 | Oral cavity and pharynx∗ | 26.44 | 9.26 | 52.43 | |
| 5 | Oral cavity and pharynx∗ | 10.86 | 3.56 | 53.83 | Oral cavity and pharynx∗ | 17.42 | 7.92 | 52.81 | Stomach (151) | 19.71 | 6.91 | 67.37 | |
| 6 | Bladder (188) | 7.04 | 2.22 | 64.48 | Bladder (188) | 10.64 | 4.75 | 72.14 | Bladder (188) | 17.46 | 6.23 | 73.23 | |
| 7 | Esophagus (150) | 5.90 | 1.90 | 62.82 | Esophagus (150) | 8.69 | 3.91 | 65.63 | Esophagus (150) | 10.79 | 3.76 | 67.32 | |
| 8 | Prostate (185) | 6.33 | 1.85 | 70.97 | Prostate (185) | 7.00 | 3.12 | 62.91 | Prostate (185) | 8.97 | 3.08 | 60.93 | |
| 9 | Skin (173) | 4.11 | 1.34 | 60.24 | Skin (173) | 5.53 | 2.51 | 62.61 | Skin (173) | 8.14 | 2.82 | 64.49 | |
| 10 | Leukemia | 3.48 | 1.24 | 38.21 | Leukemia | 4.45 | 2.09 | 41.16 | Leukemia | 5.57 | 1.88 | 46.14 | |
|
| |||||||||||||
| Female | 1 | Cervix uteri (180) | 26.27 | 7.95 | 53.18 | Breast (174) | 28.99 | 17.03 | 49.53 | Breast (174) | 39.32 | 18.62 | 50.57 |
| 2 | Breast (174) | 20.95 | 6.54 | 49.05 | Cervix uteri (180) | 26.82 | 15.37 | 53.78 | Colorectum (153–154) | 28.99 | 13.00 | 63.96 | |
| 3 | Colorectum (153–154) | 16.76 | 4.81 | 60.20 | Colorectum (153–154) | 22.54 | 12.24 | 62.30 | Cervix uteri (180) | 23.69 | 11.01 | 55.22 | |
| 4 | Lung (162) | 11.91 | 3.37 | 62.14 | Lung (162) | 14.85 | 7.99 | 63.96 | Liver (155) | 21.81 | 9.61 | 64.62 | |
| 5 | Stomach (151) | 9.31 | 2.71 | 59.22 | Stomach (151) | 13.76 | 7.44 | 62.36 | Lung (162) | 19.55 | 8.73 | 65.57 | |
| 6 | Liver (155) | 8.72 | 2.52 | 59.61 | Liver (155) | 10.01 | 5.51 | 61.58 | Stomach (151) | 10.19 | 4.60 | 63.74 | |
| 7 | Thyroid gland (193) | 4.39 | 1.50 | 42.08 | Thyroid gland (193) | 6.43 | 3.95 | 43.08 | Thyroid gland (193) | 8.51 | 4.04 | 44.00 | |
| 8 | Ovary (183) | 4.11 | 1.31 | 47.23 | Ovary (183) | 5.28 | 3.09 | 18.16 | Skin (173) | 7.24 | 3.25 | 64.87 | |
| 9 | Skin (173) | 3.60 | 1.04 | 59.97 | Skin (173) | 5.20 | 2.83 | 62.41 | Ovary (183) | 6.63 | 3.08 | 49.83 | |
| 10 | Leukemia | 2.67 | 0.89 | 34.80 | Leukemia | 3.94 | 2.22 | 52.26 | Corpus uteri (182) | 5.73 | 2.61 | 52.86 | |
|
| |||||||||||||
| Sex | Rank | 2003–2007 | 2008–2012 | 2013–2016 | |||||||||
| Cancer (ICD-O) | ASRw∗ | %∗ | Years∗ | Cancer (ICD-O) | ASRw∗ | %∗ | Years∗ | Cancer (ICD-O) | ASRw∗ | %∗ | Years∗ | ||
|
| |||||||||||||
| Male | 1 | Liver (155) | 56.99 | 17.82 | 61.14 | Liver (155) | 54.03 | 15.59 | 62.46 | Colorectum (153-154) | 52.63 | 15.71 | 65.92 |
| 2 | Lung (162) | 42.65 | 13.82 | 69.16 | Colorectum (153-154) | 52.02 | 15.23 | 65.88 | Liver (155) | 47.56 | 14.01 | 63.46 | |
| 3 | Colorectum (153-154) | 43.02 | 13.67 | 65.82 | Lung (162) | 45.14 | 13.44 | 69.28 | Lung (162) | 44.23 | 13.33 | 68.34 | |
| 4 | Oral cavity and pharynx∗ | 34.57 | 11.06 | 52.71 | Oral cavity and pharynx∗ | 41.40 | 11.95 | 54.08 | Oral cavity and pharynx∗ | 42.72 | 12.27 | 55.79 | |
| 5 | Prostate | 21.29 | 7.03 | 73.61 | Prostate (185) | 28.49 | 8.46 | 73.47 | Prostate (185) | 29.72 | 8.96 | 72.81 | |
| 6 | Stomach | 17.16 | 5.60 | 68.36 | Stomach (151) | 15.55 | 4.71 | 68.93 | Esophagus (150) | 14.44 | 4.26 | 58.67 | |
| 7 | Esophagus (150) | 11.34 | 3.60 | 59.13 | Esophagus (150) | 13.58 | 3.98 | 58.19 | Stomach (151) | 13.48 | 4.17 | 69.35 | |
| 8 | Bladder (188) | 10.60 | 3.43 | 68.28 | Skin (173) | 10.66 | 3.20 | 68.43 | Skin (173) | 11.62 | 3.57 | 70.34 | |
| 9 | Skin (173) | 9.00 | 2.89 | 66.16 | Bladder (188) | 9.51 | 2.85 | 69.53 | Bladder (188) | 9.03 | 2.78 | 69.91 | |
| 10 | Leukemia | 7.52 | 2.22 | 53.02 | Non-hodgkin lymphoma | 8.01 | 2.27 | 60.87 | Non-hodgkin lymphoma | 8.47 | 2.42 | 62.18 | |
|
| |||||||||||||
| Female | 1 | Breast (174) | 49.70 | 21.61 | 51.89 | Breast (174) | 63.14 | 23.89 | 53.65 | Breast (174) | 71.91 | 25.26 | 54.99 |
| 2 | Colorectum (153-154) | 32.14 | 13.89 | 64.84 | Colorectum (153-154) | 36.13 | 14.40 | 65.68 | Colorectum (153-154) | 35.74 | 13.98 | 66.12 | |
| 3 | Liver (155) | 22.17 | 9.66 | 66.72 | Lung (162) | 25.48 | 10.16 | 66.22 | Lung (162) | 28.62 | 11.18 | 65.86 | |
| 4 | Lung (162) | 21.70 | 9.40 | 66.17 | Liver (155) | 21.85 | 8.64 | 68.78 | Liver (155) | 18.80 | 7.48 | 69.77 | |
| 5 | Cervix uteri (180) | 15.20 | 6.61 | 56.36 | Thyroid gland (193) | 13.45 | 4.75 | 47.37 | Thyroid gland (193) | 17.29 | 5.49 | 48.97 | |
| 6 | Stomach (151) | 9.34 | 4.08 | 65.20 | Cervix uteri (180) | 11.07 | 4.26 | 57.47 | Corpus uteri (182) | 13.48 | 4.81 | 55.18 | |
| 7 | Thyroid gland (193) | 9.46 | 3.98 | 46.35 | Corpus uteri (182) | 10.94 | 4.18 | 54.05 | Skin (173) | 8.59 | 3.57 | 71.68 | |
| 8 | Skin (173) | 7.72 | 3.37 | 67.29 | Stomach (151) | 8.69 | 3.51 | 66.67 | Cervix uteri (180) | 8.72 | 3.12 | 57.83 | |
| 9 | Corpus uteri (182) | 7.72 | 3.34 | 52.99 | Skin (173) | 8.43 | 3.47 | 70.14 | Ovary (183) | 9.09 | 3.03 | 52.75 | |
| 10 | Ovary (183) | 7.36 | 3.12 | 51.17 | Ovary (183) | 8.31 | 3.04 | 51.77 | Stomach (151) | 7.50 | 2.99 | 67.78 | |
ASRw: age-standardized rate for the world population expressed as the number of incident cases per 100,000 individuals. %: the percentage of specific cancer incident cases in all incident cases. Years: the mean age of specific cancer incident cases. Oral caves and pharynx: the cancers of oral cavity and pharynx are classified to 140–146, 148–149.